Stock 1011 CHINA NT PHARMA GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company China NT Pharma Group Company Limited

Equities

1011

KYG2114L1059

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 03:00:11 2024-04-29 am EDT 		5-day change 1st Jan Change
0.027 HKD +3.85% Intraday chart for China NT Pharma Group Company Limited +17.39% -50.91%
Mar. 28 China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 15 China NT Pharma Group Company Limited Announces Directorate Changes CI

Business Summary

CHINA NT PHARMA GROUP COMPANY LIMITED is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.

Number of employees: 16

Sales per Business

HKD in Million2021Weight2022Weight Delta
Proprietary Products
100.0 %
273 100.0 % 241 100.0 % -11.86%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
273 100.0 % 241 100.0 % -11.86%

Managers

Managers TitleAgeSince
Tit Ng CEO
 Chief Executive Officer 60 94-12-31
Jing Fang DFI
 Director of Finance/CFO 55 19-05-26

Members of the board

Members of the board TitleAgeSince
Yu Biao Zhao BRD
 Director/Board Member 54 19-12-30
Tit Ng CEO
 Chief Executive Officer 60 94-12-31
Yu Chin FOU
 Founder 60 94-12-31
Wei Qian BRD
 Director/Board Member 67 10-02-28
Tze Shan Yu BRD
 Director/Board Member 67 17-06-28
Ming Kwan Ng BRD
 Director/Board Member 47 23-01-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,640,895,000 1,246,248,704 ( 47.19 %) 0 47.19 %

Company contact information

China NT Pharma Group Co., Ltd.

28/F, The Wellington 198 Wellington Street

, Hong Kong

+

http://www.ntpharma.com
address China NT Pharma Group Company Limited(1011)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHINA NT PHARMA GROUP COMPANY LIMITED Stock China NT Pharma Group Company Limited
-50.91% 8.77M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.69% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.31% 14.09B
CIPLA LIMITED Stock Cipla Limited
+11.92% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.48% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1011 Stock
  4. Company China NT Pharma Group Company Limited